Global Anatomic Pathology Market Outlook 2030
14 Sep 2021
Healthcare & Pharmaceuticals
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
The Research Report is Updated with 2020 Base Year, 2021 Estimated year and Forecast till 2030 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2020 as base year, 2021 as estimated year and forecast to 2030. This will have market drivers, recovery rate in the market, insights and competitive analysis.
The global anatomical pathology market size in 2021 is estimated to be around ~ USD 20 billion, and is expected to grow at a compound annual growth rate of 8% during the forecast period 2022-2030. The increase in the clinical use of biomarkers enables pathologists to determine the pathogenesis of the disease at the molecular level and guide clinical decision-making, thereby improving the prognosis of patients. Increasing reliance on biomarker-based pathological tests and procedures to explore common malignancies and tumorigenesis is driving market development.
The extensive use of advanced pathology equipment, such as staining systems, gross imaging and digital microscopes, is expected to improve the practice of pathology anatomy to a large extent. Compared with traditional technologies, digital imaging solutions have advantages in terms of accuracy and specificity, thereby increasing the acceptance rate of services in the general market.
The company is constantly striving to develop advanced pathology equipment and keep up-to-date in its design and technology. Easy to use. use. In addition, in order to introduce an effective product portfolio to overcome challenges related to disease management, there have been several key business partnerships and agreements.
For example, in October 2018, Sakura Finetek USA collaborated with Laboratory Medicine and Henry Ford Health System Pathology to improve the automation level of its pathology laboratory. Incorporating automation into the laboratory optimizes the anatomical pathology workflow by minimizing errors and response time, and provides high productivity.
A large number of pathology training programs by government authorities aim to raise awareness of the technical and legal issues that are common in anatomical pathology. These training modules also emphasize the theoretical knowledge of students, so as to solve the market challenge of a shortage of qualified professionals.
A PRODUCT AND SERVICE INFORMATION:
A large number of reagents and kits, antibodies and probes for anatomical pathology protocols are sold on the market. Some key reagents and kits include Tamping Tool Kits, Thermo Fisher CISH Centromere test kit, UltraView SISH DNP test kit, Roche ISH iVIEW Blue Plus test kit and Roche instrument cleaning kit. Agilent. In the research results, the usage rate of consumables is high, which accounts for the majority of income generation.
On the other hand, continued technological advancement and concentrated efforts by market participants to provide anatomical pathology instruments with improved designs are expected to drive revenue growth in the entire instrument field. In September 2018, Sakura Finetek launched the Accu-Cut SRM 300 LT handheld microtome. This product integrates a 4-color LED backlit 3D precision drill chuck. This is a new feature that allows you to view paraffin packs in an easier way Buried tissue samples for quick viewing of translucent biopsy.
The Anatomical Pathology Protocol provides researchers with an opportunity to explore the cause and related results of the disease. Therefore, the widespread application of disease diagnosis accounted for the largest revenue share of the anatomical pathology market in 2018. This workflow helps to detect tumors and proliferating stromal cells at the inflammatory stage, thereby minimizing the costs associated with tumor eradication.
In addition, manufacturers are increasingly focusing on introducing innovative and novel diagnostic technologies, accelerating the growth of this market segment. It is expected that drug discovery and development will grow at a profitable rate during the forecast period. During the pre-clinical trial, the pathologist’s tissue analysis provided a lot of information for the drug manufacturer. Anatomical pathology plays a vital role in toxicological evaluation and is used to evaluate the adverse reactions of candidate drugs.
END USE INFORMATION:
Due to the high hospitalization rate of cancer patients and the large and frequent readmission rate, hospitals dominated the market in terms of revenue in 2018. In addition, the well-developed infrastructure and the presence of well-trained staff in the hospital pathology laboratory have stimulated the development of the hospital sector. The sector is also expected to benefit from more and more initiatives taken by public and private institutions to promote advanced healthcare systems.
The emergence of advanced testing equipment and technology has created profitable growth opportunities for the field of diagnostic laboratories. Similarly, a large number of clinical trials conducted through various ongoing projects have promoted the development of the research laboratory sector. The research laboratory is committed to providing fast and complete information about the function of diseased tissues, with the overall goal of obtaining a high degree of patient satisfaction.
North America had the largest revenue share in 2020 due to the existence of major players and government support initiatives related to pathology training programs. Due to the favorable reimbursement policy in the United States, more and more implementation of tissue diagnosis-related procedures in disease screening promotes regional market growth.
Increased demand for advanced imaging methods, increase of better imaging facilities, patient care and various pathology laboratories to allow its existence Serving the Asia-Pacific market. Public institutions designed to assist pathology projects, such as the existence of the Pathology Branch of the Chinese Medical Association of China, also contribute to regional growth.
MAJOR COMPANIES AND MARKET SHARE PROSPECTS :
Well-known companies operating in this market include Thermo Fisher Scientific, Inc.; Cardinal Health; F. Hoffmann-La Roche AG; Agilent Technologies; Sakura Finetek USA, Inc.; Quest Diagnostics; American Laboratory Holdings; NeoGenomics Laboratories, Inc.; Biological Gene; and Biological SB. These major players are implementing multiple strategies to maintain their significant market share during the forecast period. The strategies implemented include collaborative development, business expansion and product development. For example, in June 2018, Agilent Technologies introduced a series of probes for in situ hybridization, including MALT1, BCL2, CCND1, MYC, BCL6, IGH, IGH/MYC, IGH/BCL2, and IGH/CCND1. The introduction of these products has improved the compans product portfolio, thereby consolidating its position in the industry.
MARKET SEGMENTS COVERED BY THE REPORT :
The report forecasts global, regional, and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global anatomical pathology market based on products and services, applications, end-uses, and regions: product and service outlook (revenue, USD million, 2022-2030), instrument slicers and Cryostat processor tissue auto-staining Other products Consumables reagents and antibody probes and kits and other service application prospects (revenue, millions of dollars, 2022-2030) disease diagnosis drug discovery and development of other end-use prospects (income, millions USD, 2022-2030) Hospital Research Laboratory Diagnostic Laboratory Other.
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook